Circadian variability of insulin sensitivity: Physiological input for in silico artificial pancreas

Diabetes Technology and Therapeutics

Volumn 17, Issue 1, 2015, Pages 1-7

  Visentin, Roberto ^a   Dalla Man, Chiara ^a   Kudva, Yogish C ^b   Basu, Ananda ^b   Cobelli, Claudio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLUCOSE BLOOD LEVEL;

ADULT; ANALYSIS OF VARIANCE; AREA UNDER THE CURVE; ARTICLE; ARTIFICIAL PANCREAS; CIRCADIAN RHYTHM; CLINICAL ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; ADOLESCENT; BLOOD; COMPUTER SIMULATION; FOOD AND DRUG ADMINISTRATION; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; MEAL; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; REPRODUCIBILITY; UNITED STATES; VALIDATION STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; AREA UNDER CURVE; BLOOD GLUCOSE; CIRCADIAN RHYTHM; COMPUTER SIMULATION; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; MEALS; MIDDLE AGED; PANCREAS, ARTIFICIAL; REPRODUCIBILITY OF RESULTS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; YOUNG ADULT;

EID: 84920842830     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2014.0192     Document Type: Article

References (24)

1. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Tamborlane WV, Beck RW, et al.: Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008;359:1464-1476.
2. Pickup JC: Insulin-pump therapy for type 1 diabetes mellitus. N Engl J Med 2012;366:1616-1624.
3. Cobelli C, Renard E, Kovatchev B: Artificial pancreas: past, present, future. Diabetes 2011;60:2672-2682.
4. Weinzimer SA, Steil GM, Swan KL, et al.: Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care 2008;31:934-939.
5. Hovorka R, Allen JM, Elleri D, et al.: Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial. Lancet 2010; 375:743-751.
6. El-Khatib FH, Russell SJ, Nathan DM, et al.: A bihormonal closed-loop artificial pancreas for type 1 diabetes. Sci Transl Med 2010;2:27ra2.
7. Kovatchev B, Cobelli C, Renard E, et al.: Multi-national study of subcutaneous model-predictive closed-loop control in type 1 diabetes: summary of the results. J Diabetes Sci Technol 2010;4:1374-1381.
8. Hovorka R, Kumareswaran K, Harris J, et al.: Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies. BMJ 2011;342:d1855.
9. Atlas E, Nimri R, Miller S, et al.: MD-Logic artificial pancreas system: a pilot study in adults with type 1 diabetes. Diabetes Care 2010;33:1072-1076.
10. Kovatchev BP, Renard E, Cobelli C, et al.: Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas. Diabetes Care 2013;36: 1851-1858.
11. Cobelli C, Renard E, Kovatchev BP, et al.: Pilot studies of wearable outpatient artificial pancreas in type 1 diabetes. Diabetes Care 2012;35:e65-e67.
12. Breton M, Farret A, Bruttomesso D, et al.: Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia. Diabetes 2012;61:2230-2237.
13. Kovatchev BP, Breton M, Dalla Man C, et al.: In silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes. J Diabetes Sci Technol 2009;3:44-55.
14. Dalla Man C, Micheletto F, Lv D, et al.: The UVA/PADOVA type 1 diabetes simulator: new features. J Diabetes Sci Technol 2014;8:26-34.
15. Visentin R, Dalla Man C, Kovatchev B, et al.: The University of Virginia/Padova type 1 diabetes simulator matches the glucose traces of a clinical trial. Diabetes Technol Ther 2014;16:428-434.
16. Hinshaw L, Dalla Man C, Nandy DK, et al.: Diurnal pattern of insulin action in type 1 diabetes: implications for a closed-loop system. Diabetes 2013;62:2223-2229.
17. Toffanin C, Zisser H, Doyle FJ 3rd, et al.: Dynamic insulin on board: incorporation of circadian insulin sensitivity variation. J Diabetes Sci Technol 2013;7:928-940.
18. CobelliC,DallaMan C, Sparacino G, et al.: Diabetes:models, signals, and control. IEEE Rev Biomed Eng 2009;2:54-96.
19. Manohar C, Levine JA, Nandy DK, et al.: The effect of walking on postprandial glycemic excursion in patients with type 1 diabetes and healthy people. Diabetes Care 2012; 35:2493-2499.
20. Schiavon M, Hinshaw L, Mallad A, et al.: Postprandial glucose fluxes and insulin sensitivity during exercise: a study in healthy individuals. Am J Physiol Endocrinol Metab 2013;305:E557-E566.
21. Breton MD: Physical activity-the major unaccounted impediment to closed loop control. J Diabetes Sci Technol 2008;2:169-174.
22. Turksoy K, Quinn LT, Littlejohn E, et al.: An integrated multivariable artificial pancreas control system. J Diabetes Sci Technol 2014;8:498-507.
23. Bergenstal RM, Tamborlane WV, Ahmann A, et al.: Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med 2010;363:311-320.
24. Schiavon M, Dalla Man C, Kudva YC, et al.: Quantitative estimation of insulin sensitivity in type 1 diabetic subjects wearing a sensor augmented insulin pump. Diabetes Care 2014;37:1216-1223.